Medical treatment of overactive bladder [3] (multiple letters)

Mayo Clinic Proceedings

Volumn 76, Issue 11, 2001, Pages 1179-1180

  Rackley, R ^a   Appell, R A ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OXYBUTYNIN; PLACEBO; TOLTERODINE;

BLADDER DISEASE; DRUG EFFICACY; HUMAN; LETTER; OVERACTIVE BLADDER; STATISTICAL ANALYSIS; TREATMENT OUTCOME; URGE INCONTINENCE;

EID: 0034761324     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/76.11.1179     Document Type: Letter

References (4)

1. RA Appell P Sand R Dmochowski OBJECT Study Group Prospective randomized controlled trial of extended-release oxybutynin chloride and tolterodine tartrate in the treatment of over-active bladder: results of the OBJECT study Mayo Clin Proc 76 2001 358 363
2. RGD Steel JH Torrie Principles and Procedures of Statistics 1960 McGraw-Hill New York, NY 22 25
3. WG Cochran GM Cox Experimental Designs 2nd ed. 1992 Wiley New York, NY 50 53
4. P Van Kerrebroeck K Kreder U Jonas N Zinner A Wein Tolterodine Study Group Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder Urology 57 2001 414 421